Anastasia Mochalova

Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial

Sumanta K. Pal, Laurence Albigès, Piotr Tomczak et al. · The Lancet · 2023 · 198 citations · Full text

Medicine, Oncology, Pharmacology +16

Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19

Roberto Caricchio, Antonio Abbate, Jamie Meng et al. · JAMA · 2021 · 166 citations · Full text

Medicine, Immunology, Pharmacotherapy +11

CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy

Joel W. Neal, Nick Pavlakis, Sang‐We Kim et al. · Journal of Clinical Oncology · 2024 · 58 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A targeted approach to viral marketing

Anastasia Mochalova · Electronic Commerce Research and Applications · 2014 · 43 citations

Business, Marketing, Marketing Management +9

RESTRICTING THE SPREAD OF FIRESTORMS IN SOCIAL NETWORKS

Anastasia Mochalova, Αλέξανδρος Νανόπουλος · Journal of the Association for Information Systems · 2014 · 17 citations

Business, Communication, Marketing +15